Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Growth Differ ; 8(2): 121-31, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9040934

ABSTRACT

Recent studies have hinted that there may be a relationship between p53 and the immune response. In preliminary experiments, we found significantly decreased levels of immunoglobulin deposition in 13 of 16 p53-null tumors compared with 2 of 17 tumors derived from p53 +/- mice. We further explored the effect of p53 on B-cell development and function. p53-null mice contained more splenic white pulp and more immature B cells in the bone marrow compared with p53 +/- mice. p53-null B cells were hyperresponsive to proliferative challenge but were not more resistant to signal-induced apoptosis. Several p53 DNA-binding sites were localized to the regulatory regions of immunoglobulin heavy and light chain genes, including the KII site, which serves as an enhancer for rearrangement of the mouse kappa chain J cluster genes. Levels of p53 protein and the kappa chain sterile transcript increased after exposure of pre-B cells to the DNA damaging agents etoposide and Adriamycin. Our observations suggest that p53 may be involved in B-cell maturation and may relay certain stress signals to affect B-cell function.


Subject(s)
B-Lymphocytes/immunology , Genes, p53/genetics , Genes, p53/immunology , Glioblastoma/immunology , Immunoglobulins/genetics , Immunoglobulins/metabolism , Animals , Antigens, Neoplasm/immunology , Binding Sites , Blotting, Western , Bone Marrow/immunology , Bone Marrow/pathology , Cell Differentiation , DNA-Binding Proteins/metabolism , Female , Genes, Regulator , Genotype , Glioblastoma/genetics , Glioblastoma/metabolism , Lipopolysaccharides/pharmacology , Lymphocyte Count , Mice , Mice, Knockout , Mice, Transgenic , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...